Screen LibraryAcute myeloid leukemia : methods and protocols /
Saved in:
| Group Author: | ; ; ; |
|---|---|
| Published: |
Humana Press,
|
| Publisher Address: | New York, NY : |
| Publication Dates: | [2017] |
| Literature type: | eBook |
| Language: | English |
| Series: |
Methods in molecular biology,
1633 Springer protocols |
| Subjects: | |
| Carrier Form: | xi, 278 pages : illustrations (some color), forms ; 26 cm. |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: |
9781493971404 (hardback : alkaline paper) : 1493971409 (hardback : alkaline paper) 9781493971428 (eBook) 1493971425 (eBook) |
| Index Number: | RC643 |
| CLC: | R733.71 |
| Call Number: | R733.71/A189-1 |
| Contents: |
Molecular malfeasance mediating myeloid malignancies : the genetics of acute myeloid leukemia / Cytochemical staining / Immunohistochemistry in acute myeloid leukemia / Immunophenotyping by multiparameter flow cytometry / Single-cell mass cytometry of acute myeloid leukemia and leukemia stem/progenitor cells / Design and application of multiplex PCR seq for the detection of somatic mutations associated with myeloid malignancies / AMLprofiler : a diagnostic and prognostic microarray for acute myeloid leukemia / Microsphere-based assessment of DNA methylation for AML prognosis / Genome-wide analysis of DNA methylation in hematopoietic cells : DNA methylation analysis by WGBS / Detection and quantification of acute myeloid leukemia-associated fusion transcripts / Targeted next-generation sequencing of acute leukemia / Bioinformatics data analysis of next-generation sequencing data from heterogeneous tumor samples / Zebrafish model for evaluating the function of human leukemic gene IDH1 and its mutation / Measurement of oncometabolites d-2-hydroxyglutaric acid and l-2-hydroxyglutaric acid / Nanofluidic allele-specific digital PCR method for quantifying IDH1 and IDH2 mutation burden in acute myeloid leukemia / Isolation of biologically active exosomes from plasma of patients with cancer / Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia / |